A major UK study has discovered that the disturbed sleep patterns in patients hospitalised with COVID-19 was likely to be a driver of breathlessness.
Greater Manchester researchers have shown for the first time that malfunctioning behaviour of a type of immune cell is linked to specific symptoms of Long COVID.
A researcher at Manchester BRC has won a celebrated international prize, in recognition for his work in respiratory (breathing) research.
Research into a new generation of a graphene-based diagnostic test – which could identify patients who need antibiotics in minutes, instead of hours – will be delivered in Manchester.
Three researchers from Manchester Biomedical Research Centre (BRC) have been appointed Senior Investigators by the National Institute for Health Research (NIHR).
The results of the world’s first Phase 3 trials, of a new drug Gefapixant, show that it can ease the often distressing symptoms of chronic cough, with minimal side effects.
Professor Paul Dark, Non-fungal Infections Programme Lead, is one of the authors of the paper “Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19,” recently published in JAMA.
A study of tuberculosis (TB) patients in six Jakarta hospitals has revealed up to 13 per cent of them had fungal lung infection – or aspergillosis – at the end of their treatment.